TARO Company Profile and Key Details
Taro Pharmaceutical Industries Ltd.
TARO Stock Price Chart
Stock Price Today
Taro Pharmaceutical Industries Ltd. (TARO) stock surged +0.01%, trading at $42.98 on NYSE, up from the previous close of $42.97. The stock opened at $42.97, fluctuating between $42.94 and $42.98 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Company Information
| Employees | 1554 |
| Beta | 0.56 |
| Sales or Revenue | $629.18M |
| 5Y Sales Change% | -0.075% |
| Fiscal Year Ends | March |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) stock price is $42.98 in the last trading session. During the trading session, TARO stock reached the peak price of $42.98 while $42.94 was the lowest point it dropped to. The percentage change in TARO stock occurred in the recent session was 0.01% while the dollar amount for the price change in TARO stock was $0.01.
The NYSE listed TARO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Taro Pharmaceutical Industries Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Uday V. Baldota
Chief Executive Officer & Director
Mr. William J. Coote
Vice President, Chief Financial Officer & Chief Accounting Officer
Mr. Itamar Karsenti
Vice President & Head of Operations
Mr. Avi Avramoff
Vice President and Head of R&D
Mr. Itzik Baruch
Vice President of Technical Services
Dr. Roman Kaplan
Vice President of Scientific and Technical Compliance Mang.
Mr. Erik Zwicker J.D.
Vice President, Gen. Counsel & Sec.
Mr. Ara Aprahamian
Vice President of Sales & Marketing
Ms. Michele Visosky
Vice President & Head of Human Resource
Mr. Jayesh Shah
Head of Procurement
TARO's closing price is 31.54% higher than its 52-week low of $32.67 where as its distance from 52-week high of $45.76 is -6.09%.
Number of TARO employees currently stands at 1,554.
Official Website of TARO is: https://www.taro.com
TARO could be contacted at phone 972 484 75700 and can also be accessed through its website. TARO operates from 14 Hakitor Street, Haifa, 2624761, Israel.
TARO stock volume for the day was 147.06K shares. The average number of TARO shares traded daily for last 3 months was 32.93K.
The market value of TARO currently stands at $1.62B with its latest stock price at $42.98 and 37.58M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com